Correlation Between AP Mller and Zealand Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AP Mller and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AP Mller and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AP Mller and Zealand Pharma AS, you can compare the effects of market volatilities on AP Mller and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AP Mller with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AP Mller and Zealand Pharma.

Diversification Opportunities for AP Mller and Zealand Pharma

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between MAERSK-B and Zealand is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding AP Mller and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and AP Mller is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AP Mller are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of AP Mller i.e., AP Mller and Zealand Pharma go up and down completely randomly.

Pair Corralation between AP Mller and Zealand Pharma

Assuming the 90 days trading horizon AP Mller is expected to under-perform the Zealand Pharma. In addition to that, AP Mller is 1.27 times more volatile than Zealand Pharma AS. It trades about -0.22 of its total potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.16 per unit of volatility. If you would invest  75,650  in Zealand Pharma AS on October 20, 2024 and sell it today you would lose (4,300) from holding Zealand Pharma AS or give up 5.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AP Mller   vs.  Zealand Pharma AS

 Performance 
       Timeline  
AP Mller 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AP Mller has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, AP Mller is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

AP Mller and Zealand Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AP Mller and Zealand Pharma

The main advantage of trading using opposite AP Mller and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AP Mller position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.
The idea behind AP Mller and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets